To prospectively describe patient-centered and health utilization outcomes through 12 months after cryoneurolysis performed as routine clinical care for chronic pain at Yale.
Diagnosis of chronic pain (generally pain duration of at least 3-6 months) localized to an anatomical region appropriate for cryoneurolysis as determined by the treating physician.
Planned cryoneurolysis procedure as part of standard clinical care.
Ability to provide written informed consent.
Ability and willingness to complete baseline and follow-up questionnaires.
Cryoneurolysis performed as part of a separate investigational trial in which data sharing is not permitted.
Active infection or other clinical contraindication to the procedure as determined by the treating clinician.
Life expectancy of less than 12 months in the judgment of the treating clinician.
Any condition that, in the investigator's opinion, would interfere with study participation or completion of follow-up, such as severe psychiatric instability or active substance use that precludes reliable follow-up